Ayala Pharmaceuticals Inc (ADXS) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ayala Pharmaceuticals Inc   (ADXS)


Ayala Pharmaceuticals Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ayala Pharmaceuticals Inc's ROI in the fourth quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Ayala Pharmaceuticals Inc 's return on investment (ROI) in its fourth quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM - -93.78 % -75.27 % -60.86 % -48.98 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -16 -4 1 10 2
Return On Investment (TTM) - - -339.23 % -181.95 % -107.36 %
ADXS's Overall Ranking # # # # #
Seq. Investment Change TTM - -77.51 % -43.12 % -28.78 % -31.77 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -48 -33 -30 -29 -24

ADXS Company Profile >> Back to ADXS Roi Comparisons >> See Annual ADXS Return On Investment



Return On Investment ADXS's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Ayala Pharmaceuticals Inc's IV. Quarter Investments $ -16 Millions ADXS's Balance sheet
Ayala Pharmaceuticals Inc's IV. Quarter Income $ -25 Millions Quarterly ADXS's Income Statement
ADXS's Income by Division See ADXS's Income by Division


ADXS Annual Return On Investment (Dec 31 2023)
2023		 (Oct 31 2022)
2022		 (Oct 31 2021)
2021		 (Oct 31 2020)
2020		 (Oct 31 2019)
2019
Total Investments in Millions -16 24 39 35 41
Y / Y Investment Growth - -39.26 % 10.4 % -13.5 % 3.4 %
Net Income in Millions -48 -14 -18 -26 -17
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -60.77 % -45.92 % -75.12 % -40.78 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ADXS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ADXS's Competitors
Subscribers only: Roi for Ayala Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ADXS's Customers

Other Ratios
ADXS's Roa ADXS's Inventory Turnover Ratio ADXS's Growth Rates ADXS's Dividend Statistics
ADXS's Profitability Ratios ADXS's Asset Turnover Ratio ADXS's Dividend Growth
ADXS's Roe ADXS's Valuation Ratios ADXS's Financial Strength Ratios ADXS's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI
Polypid Ltd  801.93 %
Redhill Biopharma Ltd   628.54 %

Date modified: 2026-09-08T15:11:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.